General Information of the Compound
Compound ID
CP0840908
Compound Name
PF-477736
    Show/Hide
Synonyms
PF-477736
    Show/Hide
Structure
Formula
C22H25N7O2
Molecular Weight
419.489
Canonical SMILES
Cn1cc(-c2[nH]c3cc(NC(=O)[C@H](N)C4CCCCC4)cc4c3c2C=NNC4=O)cn1
    Show/Hide
InChI
InChI=1S/C22H25N7O2/c1-29-11-13(9-25-29)20-16-10-24-28-21(30)15-7-14(8-17(27-20)18(15)16)26-22(31)19(23)12-5-3-2-4-6-12/h7-12,19,27H,2-6,23H2,1H3,(H,26,31)(H,28,30)/t19-/m1/s1
    Show/Hide
InChIKey
NDEXUOWTGYUVGA-LJQANCHMSA-N
Physicochemical Property
logP
2.4918
Rotatable Bonds
4
Heavy Atom Count
31
Polar Areas
130.19
Hydrogen Bond Donor Count
4
Hydrogen Bond Acceptor Count
6
Complexity
31

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 135565545
SID: 26738683
ChEMBL ID
CHEMBL3990456
DrugBank ID
DB12611
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02178, LIM domain kinase 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 = 398.11 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 IC50 = 173.78 nM
2 IC50 = 812.83 nM
Protein ID: PT01347, LIM domain kinase 2
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 = 275.42 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 IC50 = 3388.44 nM
2 IC50 > 10000 nM
Clinical Information about the Compound
Drug 1 ( PF-477736 )
Drug Name PF-477736
Company Pfizer
Indication
Advanced solid tumour
Discontinued in Phase 1
Target(s)
Checkpoint kinase-1 (CHK1)
Inhibitor